These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15096328)
1. An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover. Cairns AP; Wright SA; Taggart AJ; Coward SM; Wright GD Ann Rheum Dis; 2005 Feb; 64(2):338-9. PubMed ID: 15096328 [No Abstract] [Full Text] [Related]
2. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis. Toussirot E; Wendling D Curr Opin Rheumatol; 2007 Jul; 19(4):340-5. PubMed ID: 17551363 [TBL] [Abstract][Full Text] [Related]
3. Treatment of active ankylosing spondylitis with pamidronate. Haibel H; Brandt J; Rudwaleit M; Soerensen H; Sieper J; Braun J Rheumatology (Oxford); 2003 Aug; 42(8):1018-20. PubMed ID: 12869678 [No Abstract] [Full Text] [Related]
4. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial. Santra G; Sarkar RN; Phaujdar S; Banerjee S; Siddhanta S Singapore Med J; 2010 Nov; 51(11):883-7. PubMed ID: 21140116 [TBL] [Abstract][Full Text] [Related]
5. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Solau-Gervais E; Soubrier M; Gerot I; Grange L; Puechal X; Sordet C; Sibilia J; Duquesnoy B Rheumatology (Oxford); 2006 Mar; 45(3):339-42. PubMed ID: 16249241 [TBL] [Abstract][Full Text] [Related]
6. Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial. Wilkinson JM; Eagleton AC; Stockley I; Peel NF; Hamer AJ; Eastell R J Orthop Res; 2005 Jan; 23(1):1-8. PubMed ID: 15607868 [TBL] [Abstract][Full Text] [Related]
7. Treatment of ankylosing spondylitis with pamidronate: an open label study. Grover R; Shankar S; Aneja R; Marwaha V; Gupta R; Kumar A Ann Rheum Dis; 2006 May; 65(5):688-9. PubMed ID: 16611869 [No Abstract] [Full Text] [Related]
8. Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases. Toussirot E; Le Huédé G; Lohse A; Cédoz JP; Wendling D Clin Exp Rheumatol; 2006; 24(3):348. PubMed ID: 16870109 [No Abstract] [Full Text] [Related]
9. The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis. Slobodin G; Rosner I; Rimar D; Boulman N; Rozenbaum M; Odeh M Clin Rheumatol; 2010 Jul; 29(7):793-4. PubMed ID: 20111975 [TBL] [Abstract][Full Text] [Related]
10. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate. Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330 [TBL] [Abstract][Full Text] [Related]
11. New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate. Davis JC; Huang F; Maksymowych W Rheum Dis Clin North Am; 2003 Aug; 29(3):481-94, viii. PubMed ID: 12951863 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of ankylosing spondylitis with acemetacin, a new non-steroidal antirheumatic agent]. Peter E; Hartl PW Med Welt; 1982 Nov; 33(45):1600-6. PubMed ID: 7176885 [No Abstract] [Full Text] [Related]
13. [Feldene (piroxicam) in the treatment of ankylosing spondylitis]. Sadowska-Wróblewska M; Garwolińska H; Radzikowska B Reumatologia; 1983; 21(1):55-8. PubMed ID: 6359311 [No Abstract] [Full Text] [Related]
14. An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis. Clunie GP; Ginawi A; O'Conner P; Bearcroft PW; Garber SJ; Bhagat S; Grainger A; Gaston JS Ann Rheum Dis; 2014 Jun; 73(6):1273-4. PubMed ID: 24521738 [No Abstract] [Full Text] [Related]
15. Pamidronate--a promising new candidate for the management of spondyloarthropathy. Akerkar SM; Bichile LS Indian J Med Sci; 2005 Apr; 59(4):165-70. PubMed ID: 15876783 [TBL] [Abstract][Full Text] [Related]
16. [Anti-inflammatory treatment of ankylosing spondylitis (author's transl)]. Doury P; Pattin S Sem Hop; 1980 Jan 8-15; 56(1-2):89-91. PubMed ID: 6244637 [TBL] [Abstract][Full Text] [Related]
17. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response. Kim TH; Stone M; Payne U; Zhang X; Ionescu M; Lobanok T; King L; Poole AR; Inman RD Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093 [TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis]. Sadkiewicz S; Barwik-Schramm A; Grzywa M; Letkiewicz C; Piotrowska E; Procel Z; Reszkowska H; Wippel A; Woźniak M; Zmudzińska I Reumatologia; 1982; 20(1-2):75-80. PubMed ID: 6761815 [No Abstract] [Full Text] [Related]
19. Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial. Sydnes OA Br J Clin Pract; 1981 Jan; 35(1):40-4. PubMed ID: 7020732 [No Abstract] [Full Text] [Related]
20. [Use of solasodin in the treatment of some internal diseases]. Milimovka ME; Konovalov MN; Boĭdykh RI; Kazakov MG; Rybnikov NI; Strizhevskaia AZ Vrach Delo; 1966 May; 5():62-5. PubMed ID: 5995513 [No Abstract] [Full Text] [Related] [Next] [New Search]